Results 21 to 30 of about 7,984 (250)

Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews [PDF]

open access: yes, 2018
Background Successful treatments for gestational diabetes mellitus (GDM) have the potential to improve health outcomes for women with GDM and their babies. Objectives To provide a comprehensive synthesis of evidence from Cochrane systematic reviews of
Alsweiler, Jane   +5 more
core   +1 more source

What's in a Name? Classification of Diabetes Mellitus in Veterinary Medicine and Why It Matters [PDF]

open access: yes, 2016
Diabetes Mellitus (DM) is a syndrome caused by various etiologies. The clinical manifestations of DM are not indicative of the cause of the disease, but might be indicative of the stage and severity of the disease process.
Abdul-Rasoul   +110 more
core   +3 more sources

Glycemic control and long-acting insulin analog utilization in patients with type 2 diabetes [PDF]

open access: yes, 2010
Introduction: The objective was to compare glycemic control, insulin utilization, and body weight in patients with type 2 diabetes (T2D) initiated on insulin detemir (IDet) or insulin glargine (IGlar) in a real-life setting in the Netherlands.
A. Dornhorst   +43 more
core   +1 more source

Combined insulin detemir and liraglutide therapy in type 2 diabetic patients: a base for an alliance

open access: yesСахарный диабет, 2017
Combined glucose-lowering therapy, comprising of basal insulin with glucagon-like peptide-1 (GLP-1) analogues, has become central to the treatment of type 2 diabetes both at the start of insulin therapy, and as an alternative to basal-bolus insulin.
Lyudmila Alexandrovna Ruyatkina   +1 more
doaj   +1 more source

Glycaemic control and prevalence of hypoglycaemic events in children and adolescents with type 1 diabetes mellitus treated with insulin analogues [PDF]

open access: yes, 2014
Background/Aim. An ideal insulin regimen for children and adolescents with type 1 diabetes mellitus (T1DM) should be physiological, flexibile and predictable, protecting against hypoglycaemia.
Milenković Tatjana   +5 more
core   +1 more source

Molecular characterisation of long-acting insulin analogues in comparison with human insulin, IGF-1 and insulin X10. [PDF]

open access: yesPLoS ONE, 2012
AIMS/HYPOTHESIS: There is controversy with respect to molecular characteristics of insulin analogues. We report a series of experiments forming a comprehensive characterisation of the long acting insulin analogues, glargine and detemir, in comparison ...
Bo F Hansen   +6 more
doaj   +1 more source

Cerebrocortical beta activity in overweight humans responds to insulin detemir.

open access: yesPLoS ONE, 2007
BackgroundInsulin stimulates cerebrocortical beta and theta activity in lean humans. This effect is reduced in obese individuals indicating cerebrocortical insulin resistance.
Otto Tschritter   +9 more
doaj   +1 more source

All-Cause and Cause-Specific Mortality among Users of Basal Insulins NPH, Detemir, and Glargine. [PDF]

open access: yesPLoS ONE, 2016
BACKGROUND:Insulin therapy in type 2 diabetes may increase mortality and cancer incidence, but the impact of different types of basal insulins on these endpoints is unclear.
Arto Y Strandberg   +5 more
doaj   +1 more source

Insulin Allergy to Detemir Followed by Rapid Onset of Diabetic Ketoacidosis: A Case Report and Literature Review

open access: yesFrontiers in Endocrinology, 2022
The management of diabetes mellitus in an insulin-dependent patient is challenging in the setting of concomitant antibody-mediated-insulin hypersensitivity.
Chong Boon Teo   +14 more
doaj   +1 more source

Glucose-responsive insulin activity by covalent modification with aliphatic phenylboronic acid conjugates [PDF]

open access: yes, 2014
Since its discovery and isolation, exogenous insulin has dramatically changed the outlook for patients with diabetes. However, even when patients strictly follow an insulin regimen, serious complications can result as patients experience both ...
Anderson, Daniel Griffith   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy